De Vito Andrea, Colpani Agnese, Trunfio Mattia, Fiore Vito, Moi Giulia, Fois Marco, Leoni Nicola, Ruiu Stefano, Babudieri Sergio, Calcagno Andrea, Madeddu Giordano
Unit of Infectious Diseases, Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.
Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, 10149 Torino, Italy.
Vaccines (Basel). 2023 Apr 25;11(5):896. doi: 10.3390/vaccines11050896.
After 40 years of its appearance, human immunodeficiency virus (HIV) infection remains a leading public health challenge worldwide. Since the introduction of antiretroviral treatment (ART), HIV infection has become a chronic condition, and people living with HIV could have life expectancies close to those of the general population. People with HIV often have an increased risk of infection or experience more severe morbidity following exposure to vaccine-preventable diseases. Nowadays, several vaccines are available against bacteria and viruses. However, national and international vaccination guidelines for people with HIV are heterogeneous, and not every vaccine is included. For these reasons, we aimed to perform a narrative review about the vaccinations available for adults living with HIV, reporting the most updated studies performed for each vaccine among this population. We performed a comprehensive literature search through electronic databases (Pubmed-MEDLINE and Embase) and search engines (Google Scholar). We included English peer-reviewed publications (articles and reviews) on HIV and vaccination. Despite widespread use and guideline recommendations, few vaccine trials have been conducted in people with HIV. In addition, not all vaccines are recommended for people with HIV, especially for those with low CD4 cells count. Clinicians should carefully collect the history of vaccinations and patients' acceptance and preferences and regularly check the presence of antibodies for vaccine-preventable pathogens.
人类免疫缺陷病毒(HIV)感染出现40年后,仍然是全球主要的公共卫生挑战。自从引入抗逆转录病毒治疗(ART)以来,HIV感染已成为一种慢性病,HIV感染者的预期寿命可能接近普通人群。HIV感染者在接触疫苗可预防疾病后,感染风险通常会增加,或者发病会更严重。如今,有几种针对细菌和病毒的疫苗可供使用。然而,针对HIV感染者的国家和国际疫苗接种指南并不统一,并非每种疫苗都被涵盖。出于这些原因,我们旨在对可供HIV成年感染者使用的疫苗进行叙述性综述,报告针对该人群每种疫苗所开展的最新研究。我们通过电子数据库(PubMed-MEDLINE和Embase)和搜索引擎(谷歌学术)进行了全面的文献检索。我们纳入了关于HIV和疫苗接种的英文同行评审出版物(文章和综述)。尽管疫苗被广泛使用且有指南推荐,但针对HIV感染者开展的疫苗试验却很少。此外,并非所有疫苗都推荐给HIV感染者,尤其是CD4细胞计数低的患者。临床医生应仔细收集疫苗接种史以及患者的接受程度和偏好,并定期检查是否存在针对疫苗可预防病原体的抗体。